Angiogenesis blockade as a new therapeutic approach to experimental colitis.
about
Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitisMatrix metalloproteinases in inflammatory bowel disease: an updateUp-regulation of intestinal vascular endothelial growth factor by Afa/Dr diffusely adhering Escherichia coliEndogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's diseaseThalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC).ACF7 regulates inflammatory colitis and intestinal wound response by orchestrating tight junction dynamicsQuantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease.Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis.Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthBreast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin.VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel diseaseTemporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.Role of the endothelium in inflammatory bowel diseases.Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.Anti inflammatory and anti angiogenic effect of black raspberry extract on human esophageal and intestinal microvascular endothelial cells.Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function?Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.Immunopathogenesis of IBD: current state of the art.Promoting inflammatory lymphangiogenesis by vascular endothelial growth factor-C (VEGF-C) aggravated intestinal inflammation in mice with experimental acute colitis.The role of thrombospondin 1 on intestinal inflammation and carcinogenesisMRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn's disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis.Nilotinib-mediated mucosal healing in a rat model of colitis.VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy.The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8.Extraluminal factors contributing to inflammatory bowel diseaseAngiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease.Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases.Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.Poly-γ-glutamic acid attenuates angiogenesis and inflammation in experimental colitis.Thrombospondin and VEGF-R: is there a correlation in inflammatory bowel disease?FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities.Technical Advance: Function and efficacy of an {alpha}4-integrin antagonist using bioluminescence imaging to detect leukocyte trafficking in murine experimental colitis.Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition.MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury.Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury.Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39.Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions.COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis model.Inhibition of endothelial Slit2/Robo1 signaling by thalidomide restrains angiogenesis by blocking the PI3K/Akt pathway.
P2860
Q24656280-A65D949C-A1CD-48BB-85FC-7760210C1B5CQ28080664-72D16C4B-89B5-4B7A-84D8-3D8EB5B7DF3FQ33312378-D9B9B769-F10D-4A13-ADCE-F326114F0AE4Q33618488-5051D84C-1866-4BD3-A3B7-AF0485DF1742Q33655628-7C094446-04DA-423D-BAF7-048ED7E22111Q33762815-B1D1D0F0-0FFE-4530-8450-2DD8E27A9D41Q33831778-74BA1724-8402-4BE8-B2CE-3AD80E1DBE2CQ33905709-0E7E9C9A-1D83-40B4-98AB-8FBA7AC8CF79Q33915046-1FF50028-BF10-4908-AC3C-CB3E7F66CCF7Q34103283-D2DE8650-FF49-48D9-BAC2-CDA756373221Q34117538-3E14E285-BA13-439D-AA00-9AEA2AEBF1F6Q34518038-F4261F69-39AF-4555-BBAF-1DAD01BCC415Q34579746-1E05C770-EE93-4202-B3D1-877C7617391EQ34723329-C7658D6C-BD08-43A8-BCA6-4AFF04ECD878Q34765589-65AFFEB6-BA6A-4E16-B5FB-69EBD8FF73D6Q34876266-E3D69416-9344-487B-80DC-5598C107EAD1Q35624894-F40FEB64-19C4-4053-AAA8-C65342510A41Q35719490-22110B96-BD63-47A1-B60A-23F7542E06F5Q35857951-1843707B-474C-4E13-830E-1AB234B3914FQ36793577-748C4192-CDCF-43C1-B021-F0D9F15326EEQ37010223-83CA21FC-D2D6-48EB-88F4-B09248233959Q37017694-B547DD10-DE38-4035-8BC6-C649850BC143Q37208138-01A196D3-D294-4896-B4A0-0FC273569226Q37359869-3F2A514B-05FB-426D-92B9-20503FEBB03EQ37421164-70D68856-5E46-4791-974D-933676455DDDQ37847061-690BFF90-5E1D-4D88-A333-DC377A69D763Q38946679-90CADF47-1BE6-4C5E-9F60-B9EE2DE5FCF6Q39335943-B2794AF7-0B79-4FEA-A1B8-4301876A357BQ39543850-2AC56418-632D-4E75-ABB5-22FE3F74A97DQ41473406-587030AF-53A9-4A77-B47C-8F3C667AB8F2Q41857388-19DA42F9-5941-4463-A9E3-5E8DAA7FF683Q41976143-7CC9CE3F-8237-41FB-BC2B-5DF6FDF98FC6Q42925730-06995BD0-5C14-48B4-B315-66AA6E9BC887Q43072872-E9DD7782-260F-4FDF-A201-C8A5FEADCF2BQ43117122-77B4CB5D-FABC-4324-A31F-012C4B02742BQ43168068-4BA71B21-3320-47A7-AAB1-A40E48AC5C21Q46202324-56D2AD7A-99DC-4586-8B7E-C1ABE8CCEE7CQ50129416-6BF1F66C-F70B-4B55-ADA0-F228503B7FCCQ51730548-BE05962F-93D5-476A-8592-FF970A61B84FQ54314849-038B0EC9-0150-4B34-B0BA-D2579DDA07E4
P2860
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
@ast
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
@en
type
label
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
@ast
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
@en
prefLabel
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
@ast
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
@en
P2093
P2860
P356
P1433
P1476
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
@en
P2093
Alan D Levine
Andrew P Mazar
Carol de la Motte
Claudio Fiocchi
David E Shaw
David M Spencer
Fernando Doñate
Marian L Plunkett
Miquel Sans
P2860
P304
P356
10.1136/GUT.2006.114314
P407
P577
2006-12-14T00:00:00Z